Role of high density lipoproteins in the regression of atherosclerosis

J J Badimon1, V Fuster, L Badimon

  • 1Cardiac Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

Circulation
|December 1, 1992
PubMed

Insights

High levels of high-density lipoproteins (HDL) are protective against coronary artery disease (CAD). HDL acts as a scavenger, removing excess cholesterol from tissues and transporting it to the liver for metabolism.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Atherosclerosis involves cholesterol accumulation in vessel walls.
  • Plasma lipoproteins, including LDL and HDL, transport lipids.
  • Low-density lipoproteins (LDL) deliver cholesterol from the liver to tissues.

Purpose of the Study:

  • To investigate the role of high-density lipoproteins (HDL) in cholesterol transport.
  • To examine the relationship between HDL levels and coronary artery disease (CAD) incidence.

Main Methods:

  • Review of epidemiological studies and established scientific literature.
  • Analysis of the inverse relationship between plasma HDL levels and CAD incidence.

Main Results:

  • Compelling evidence indicates plasma LDL is the primary source of lipids in atherosclerotic lesions.
  • Reverse cholesterol transport, facilitated by HDL, removes cholesterol from extrahepatic tissues.
  • Studies confirm an inverse correlation between HDL plasma levels and CAD incidence.

Conclusions:

  • High plasma HDL levels are associated with protection against coronary artery disease (CAD).
  • HDL functions as a crucial scavenger particle for tissue cholesterol.
  • The protective role of HDL against CAD is supported by extensive research.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...